Giancarlo Vecchio

Activation of <i>RET</i> as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2B

Massimo Santoro, Francesca Carlomagno, Alfredo Romano et al. · Science · 1995 · 835 citations

ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases.

Francesca Carlomagno, Donata Vitagliano, Teresa Guida et al. · PubMed · 2002 · 570 citations

Available Inhibitor, Ret/papillary Thyroid Carcinoma, Nih-ret/ptc3 Cells +17

A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases

Alfredo Fusco, Michèle Grieco, Massimo Santoro et al. · Nature · 1987 · 412 citations

Endocrine-related Cancer, Oncogenic Agent, Medicine +9

Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.

Massimo Santoro, Nina Dathan, Maria Teresa Berlingieri et al. · PubMed · 1994 · 372 citations

High Prevalence of RET/PTC Rearrangements in Ukrainian and Belarussian Post-Chernobyl Thyroid Papillary Carcinomas: A Strong Correlation between RET/PTC3 and the Solid-Follicular Variant1

G Thomas, H. Bunnell, Helen Cook et al. · The Journal of Clinical Endocrinology & Metabolism · 1999 · 261 citations · Full text